Retraction Note: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
Main Authors: | Jun Dai, Rujia Wei, Peihai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Journal of Translational Medicine |
Online Access: | https://doi.org/10.1186/s12967-022-03560-y |
Similar Items
-
Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
by: Jun Dai, et al.
Published: (2019-06-01) -
PSAT1 positively regulates the osteogenic lineage differentiation of periodontal ligament stem cells through the ATF4/PSAT1/Akt/GSK3β/β-catenin axis
by: Linglu Jia, et al.
Published: (2023-02-01) -
Restored microRNA-133a-3p or Depleted PSAT1 Restrains Endothelial Cell Damage-Induced Intracranial Aneurysm Via Suppressing the GSK3β/β-Catenin Pathway
by: Qiang Jia, et al.
Published: (2020-09-01) -
PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer
by: Song Gao, et al.
Published: (2017-12-01) -
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
by: Richard L. Watson, et al.
Published: (2010-05-01)